IKT

INHIBIKASE THERAPEUTICS INC

IKT·45719W205·US·Common Stock·Healthcare - Biotechnology-13D/G

IKT (INHIBIKASE THERAPEUTICS INC) is held by 61 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($10.6M), Blackstone Inc. ($10M), VANGUARD CAPITAL MANAGEMENT LLC ($7.5M). Net institutional sentiment: Bullish.

61
Holders
Avg rating(14 Elite)
$51.8M
Total Value
82% (65)
Fund Consensus
50 buying - 11 selling
IKTSmart Money Verdict
View all
Held by 61 funds
14 elite
Who's Trading
ActivistCOCommodore Capital LP9.9%May 15, 2026
ActivistPAPerceptive Advisors LLC8.9%May 15, 2026
ActivistADADAR1 Capital Management, LLC9.9%May 15, 2026
ActivistTETrails Edge Capital Partners, LP6.1%May 15, 2026
ActivistFAFairmount Funds Management LLC9.9%Feb 17, 2026
ActivistNANantahala Capital Management, LLC5.7%Feb 13, 2026
ActivistSLSands Capital Life Sciences Pulse Fund II, L.P.10.8%Feb 13, 2026
InsiderSLSands Capital Life Sciences Pulse Fund II, L.P.Buy $3.0MNov 21, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6.3M(+90.7%)$10.6M0.0%+9.59%
44
Unchanged
5.9M$10M0.0%-14.26%
0
New
4.5M$7.5M0.0%+6.81%
38
Increased
2.9M(+1623.9%)$4.9M0.0%+6.61%
43
Increased
2.2M(+92.3%)$3.6M0.0%+1.40%
42
Increased
1.7M(+203.8%)$2.8M0.0%+10.46%
42
Decreased
1.1M(-11.3%)$1.9M0.0%+4.91%
0
New
847,611$1.4M0.0%+6.81%
35
Increased
718,800(+122.7%)$1.2M0.0%+7.46%
41
New
617,730$1M0.0%+6.81%
35
New
566,999$952,5580.0%+6.81%
35
Increased
472,399(+500.6%)$793,6300.0%+9.58%
40
Increased
322,704(+595.3%)$542,1430.0%+5.12%
27
Increased
328,518(+1222.1%)$519,0580.0%+8.21%
27
Increased
235,414(+54.6%)$395,4960.0%+18.44%
34
Increased
228,151(+141.3%)$383,2930.0%+8.30%
38
Increased
213,208(+55.1%)$358,1890.0%+18.58%
33
New
172,013$288,9820.0%+6.81%
32
Increased
164,259(+106.1%)$275,9560.0%+8.42%
26
Increased
157,988(+3.3%)$265,4200.0%-26.28%
24

Showing 1-20 of 65

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used